Global Preimplantation Genetic Testing Market Expected to Reach USD 6.72 Billion by 2035

The global preimplantation genetic testing market is projected to expand at a CAGR of approximately 13% from 2023 to 2035, reaching a revenue of USD 6.72 billion by the end of the forecast period. The growth of the market can be attributed to the increasing number of newborns with congenital genetic disorders.

Preimplantation genetic testing involves screening embryos for genetic problems before implantation. It is used to detect a variety of genetic disorders, with Down syndrome being the most common chromosomal disorder identified in the United States. Other factors driving the market growth include increasing cases of false pregnancies and miscarriages.

One of the applications of preimplantation genetic testing is tissue typing, which helps in the detection of blood disorders. This method is also useful in identifying chromosomal abnormalities in embryos and preventing congenital genetic deformities in fetuses.

The market in North America is expected to witness the highest growth, driven by technological advancements such as next-generation sequencing (NGS)-based preimplantation genetic testing. The accuracy and efficiency of genetic testing have significantly improved with the introduction of NGS-based methods. The increasing demand for assisted reproductive technologies, such as in vitro fertilization (IVF), has also contributed to the growth of the market in North America.

Europe is estimated to have the highest CAGR by 2035, with a favorable regulatory environment for preimplantation genetic testing. Clear guidelines and regulations governing the use of preimplantation genetic testing, along with research initiatives funded by the European Union, have facilitated the growth of the market in Europe. Technological advancements and the increasing prevalence of genetic disorders have also contributed to the adoption of preimplantation genetic testing in the region.

Overall, the global preimplantation genetic testing market is expected to witness significant growth in the coming years, driven by the increasing demand for genetic screening and technological advancements in genetic testing methods.